Evidence map›Paper›PMID 28360902›Full record

ReviewFrontiers in microbiology2017

The Potential of Systems Biology to Discover Antibacterial Mechanisms of Plant Phenolics.

Caroline S Rempe, Kellie P Burris, Scott C Lenaghan, C Neal Stewart

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Article
  3. ValorizingInternational journal of food science · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rapid Bactericidal Activity ofMolecules (Basel, Switzerland) · 2025
    Article
  10. Phenolic Compounds fromAntibiotics (Basel, Switzerland) · 2025
    Review
  11. Control ofFoods (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Caroline S RempeCollege of Arts and Sciences, Graduate School of Genome Science and Technology, University of Tennessee Knoxville, TN, USA.
Kellie P BurrisDepartment of Food Science, University of TennesseeKnoxville, TN, USA; Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State UniversityRaleigh, NC, USA.
Scott C LenaghanDepartment of Food Science, University of TennesseeKnoxville, TN, USA; Department of Mechanical, Aerospace, and Biomedical Engineering, University of TennesseeKnoxville, TN, USA.
C Neal StewartCollege of Arts and Sciences, Graduate School of Genome Science and Technology, University of TennesseeKnoxville, TN, USA; Department of Plant Sciences, University of TennesseeKnoxville, TN, USA.
University of Tennessee at Knoxville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug resistance of bacterial pathogens is a growing problem that can be addressed through the discovery of compounds with novel mechanisms of antibacterial activity. Natural products, including plant phenolic compounds, are one source of diverse chemical structures that could inhibit bacteria through novel mechanisms. However, evaluating novel antibacterial mechanisms of action can be difficult and is uncommon in assessments of plant phenolic compounds. With systems biology approaches, though, antibacterial mechanisms can be assessed without the bias of target-directed bioassays to enable the discovery of novel mechanism(s) of action against drug resistant microorganisms. This review article summarizes the current knowledge of antibacterial mechanisms of action of plant phenolic compounds and discusses relevant methodology.

Indexed as

antimicrobialsmechanism of actionmembranemetabolic processesmicrobial structure

Identifiers

PMID28360902
PMCPMC5352675
OpenAlexW2601082929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.